Surgical oncologist Mr Myles Smith and colleagues recently published a new study in the Journal of Surgical Oncology entitled ‘Outcome after treatment for sebaceous carcinoma: A multicenter study’.

Sebaceous carcinoma (SC) is a rare and aggressive malignant tumour, and there is limited long-term data on the outcomes for patients. This study aimed to assess the outcome of patients treated with resection for SC.

The team at the Royal Marsden Hospital, alongside colleagues at three other referral centres in the Netherlands, looked at the treatment outcomes of 100 patients that were diagnosed with SC between 1990 and 2017.

They concluded that patients with positive resection margins and (peri)ocular tumour location are more frequently associated with a local recurrence. Patients with SC infrequently present with locoregional or distant metastases, resulting in a good overall survival.

You can read the published study here.